About Kitasato University Kitasato Institute Hospital
北里大学 北里研究所病院は、東京都港区白金五丁目にある医療機関。学校法人北里研究所が運営する病院である。北里柴三郎によって設立された土筆ヶ丘養生園を起源とする。東京都の災害拠点病院に指定されている。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
11
Janssen Research & Development, LLC
5
Eli Lilly and Company
3
Galapagos NV
3
Shire
3
Arena Pharmaceuticals
2
Amgen
1
Celgene
1
Gilead Sciences
1
Janssen Pharmaceutical K.K.
1
Kowa Company, Ltd.
1
Clinical Trials at Kitasato University Kitasato Institute Hospital
During the past decade, Kitasato University Kitasato Institute Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 14 clinical trials were completed, i.e. on
average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
2012-04-01
2015-05-01
Completed
614
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
A Prospective Multi-center Study on Total Hip Arthroplasty With E1
2013-03-11
2019-03-15
Terminated
153
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
2015-07-21
2019-02-27
Completed
3,021
Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.
2016-03-02
2018-11-14
Completed
849
Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain
2016-05-26
2019-06-11
Completed
277
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
2016-11-14
2020-03-31
Completed
1,351
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kitasato University Kitasato Institute Hospital" #1 sponsor was "Pfizer" with 11 trials, followed by "Janssen Research & Development, LLC" with 5 trials
sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored and "Shire"
with 3 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kitasato University Kitasato Institute Hospital"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Kitasato University Kitasato Institute Hospital
According to Clinical.Site data, the most researched conditions in "Kitasato University Kitasato Institute Hospital" are
"Ulcerative Colitis" (20 trials), "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (2 trials), "Migraine" (2 trials) and "Osteoarthritis, Hip" (2 trials). Many other conditions were trialed in "Kitasato University Kitasato Institute Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kitasato University Kitasato Institute Hospital
Most popular intervention types in "Kitasato University Kitasato Institute Hospital" are "Drug" (32 trials), "Biological" (4 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Etrasimod" (4 trials), "Filgotinib" (4 trials), "Guselkumab" (4 trials) and "CP-690,550" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kitasato University Kitasato Institute Hospital
The vast majority of trials in "Kitasato University Kitasato Institute Hospital" are
33 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kitasato University Kitasato Institute Hospital
Currently, there are NaN active trials in "Kitasato University Kitasato Institute Hospital".
undefined are not yet recruiting,
10 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 13 completed trials in Kitasato University Kitasato Institute Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kitasato University Kitasato Institute Hospital, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".